Biopharma BD Report | Q1 2025
This report from our Commercial Advisory team details global biopharma dealmaking activity during Q1 2025. The data is summarized to give an overview of the most valuable mergers and acquisitions (M&A), partnerships and asset purchases to provide insight into BD trends.